These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 39150076)

  • 21. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 22. Black clients in expansion states who used opioids were more likely to access medication for opioid use disorder after ACA implementation.
    Johnson NL; Choi S; Herrera CN
    J Subst Abuse Treat; 2022 Feb; 133():108533. PubMed ID: 34218991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis.
    Solomon KT; Bandara S; Reynolds IS; Krawczyk N; Saloner B; Stuart E; Connolly E
    J Subst Abuse Treat; 2022 Jan; 132():108424. PubMed ID: 34144299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
    Huhn AS; Hobelmann JG; Strickland JC; Oyler GA; Bergeria CL; Umbricht A; Dunn KE
    JAMA Netw Open; 2020 Feb; 3(2):e1920843. PubMed ID: 32031650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
    Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
    J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
    Han BH; Doran KM; Krawczyk N
    J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
    Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
    Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.
    Stahler GJ; Mennis J; Stein LAR; Belenko S; Rohsenow DJ; Grunwald HE; Brinkley-Rubinstein L; Martin RA
    Drug Alcohol Depend; 2022 Jul; 236():109498. PubMed ID: 35605535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities in opioid use disorder-related hospital use among postpartum Virginia Medicaid members.
    Martin CE; Britton E; Shadowen H; Bachireddy C; Harrell A; Zhao X; Cunningham P
    J Subst Use Addict Treat; 2023 Feb; 145():208935. PubMed ID: 36880911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare.
    Gibbons JB; McCullough JS; Zivin K; Brown ZY; Norton EC
    J Subst Use Addict Treat; 2024 Feb; 157():209271. PubMed ID: 38135120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.
    Lynch V; Clemans-Cope L
    Subst Use Addctn J; 2024 Jul; 45(3):434-445. PubMed ID: 38294428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
    Tipping AD; Nowels M; Moore C; Samples H; Crystal S; Olfson M; Williams AR; Heaps-Woodruff J
    J Subst Use Addict Treat; 2024 Feb; 157():209218. PubMed ID: 37984564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost of opioid use disorder-related conditions in Medicare.
    Mark TL; Parish WJ; Weber EM; Steinberg DG; Henretty K
    Drug Alcohol Depend; 2023 Mar; 244():109778. PubMed ID: 36701935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
    Mauro PM; Gutkind S; Annunziato EM; Samples H
    JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US.
    Stahler GJ; Mennis J; Baron DA
    Drug Alcohol Depend; 2021 Sep; 226():108849. PubMed ID: 34198132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a Co-Located Bridging Recovery Initiative on Hospital Length of Stay Among Patients With Opioid Use Disorder: The BRIDGE Randomized Clinical Trial.
    Marcovitz D; Dear ML; Donald R; Edwards DA; Kast KA; Le TDV; Shah MV; Ferrell J; Gatto C; Hennessy C; Buie R; Rice TW; Sullivan W; White KD; Van Winkle G; Wolf R; Lindsell CJ;
    JAMA Netw Open; 2024 Feb; 7(2):e2356430. PubMed ID: 38411964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.